61.—(1) The Medicines for Human Use (Clinical Trials) Regulations 2004 F1 are amended as follows.
(2) In regulations—
(a)17(2)(b)(ii) (request for authorisation to conduct a clinical trial);
(b)24(10) (amendments by the sponsor);
(c)38(3)(b) (application for manufacturing authorisation); and
(d)44(8) (variation of manufacturing authorisation)
for “Medicines (Products for Human Use) (Fees) Regulations 2013” substitute “ Medicines (Products for Human Use) (Fees) Regulations 2016 ”.
Textual Amendments
F1S.I. 2004/1031; relevant amendments are made by S.I. 2006/1928 and 2013/532.